Advances in Digestive Diseases 2023

Exhibitors

AbbVie (GI Care)

AbbVie - Immunology, GI

AbbVie Hepatology / Virology

Bristol-Myers Squibb

Ferring Pharmaceutical

Gilead Sciences, Inc.

Medtronic

Medtronic is Engineering the Extraordinary

We are a groundbreaking healthcare technology solutions company, inspiring hope and possibility in people around the world.

QOL Medical

QOL Medical, LLC is a patient-centric company with a focus on the acquisition and commercialization of orphan drug therapies in underserved markets. QOL Medical’s goal is to expand clinical awareness and patient access to help make a difference in people's lives in the treatment of orphan diseases. QOL Medical currently markets two FDA-approved products: Sucraid® (sacrosidase) Oral Solution and Ethamolin® (ethanolamine oleate) Injection, 5%.

www.qolmed.com

Salix Pharmaceuticals

https://www.salix.com/

STERIS

STERIS is focused on improving patient care by delivering clinically proven product solutions and technologies in spray cryotherapy, electrosurgery, hemostasis, polypectomy, and more. We are excited to share our latest innovations and technologies as advancing patient care in GI endoscopy is our focus. The clinically-focused offerings include the truFreeze® spray cryotherapy system indicated for the treatment of esophageal and airway diseases, the state-of-the-art gi4000 electrosurgery unit, our portfolio of bleed management solutions offering complete clip coverage and our polypectomy devices optimized for the complete removal of colorectal lesions.

Takeda Pharmaceuticals USA

Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetic and Hematology, Neuroscience, and Gastroenterology (GI).